Enhance Space Agility, Compliance & Optimize Operational Spend to Achieve Maximum Efficiency in Lab Operations
The external landscape for biopharma continues to shift as demand to protect budgets increases with uncertainty around tariffs, and companies have greater responsibility to manage a surplus in excess space. Despite these changes, scientific operations continue to progress, as evidenced by Novartis recent commitment to a $23 billion investment into new US manufacturing sites and Eli Lilly & Co's plans for four new sites. Standing as the backbone of scientific support, lab operations professionals are relied upon to manage the lab with the utmost efficiency, retain a compliant working environment, optimize resources, and wear as many hats as possible to ensure R&D forever continues.
The 2nd Lab Ops & Facility Management for Biopharma Summit (LOFM), in collaboration with the likes of Sonoma Biotherapeutics, Vertex, and Ultragenyx, is uniting 60+ senior lab operations and facilities professionals to discuss critical process improvements contributing towards an efficient, safe, and sustainable lab environment to protect R&D in light of external headwinds. Network with peers and learn best practices in smart spending, outsourcing efficiency, and asset management optimization to truly bulletproof your labs against shifting demands and end user requirements.
Join your community to better operationalize your labs, move away from paper whilst remaining within budget, and make strategic decisions to support your scientists.
Attending Companies Include


















